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ABSTRACT Moderate to vigorous physical activity (MVPA) interventions reduce the severity of
obstructive sleep apnoea (OSA); however, little epidemiological research exists to confirm these findings.
789 participants from the population-based Men Androgen Inflammation Lifestyle Environment and
Stress (MAILES) Study underwent polysomnography. MVPA was assessed using the Active Australia
questionnaire, which was completed when participants were first recruited to the MAILES study
(2002–2006), and again in 2010. Multinomial logistic regressions established odds ratio between OSA
severity categories with MVPA, whilst adjusted linear models determined associations between OSA
metrics with MVPA.
Cross-sectionally, each hour of MVPA was associated with reduced severity of mean oxygen
desaturation (unstandardised β (B)=−0.002, p=0.043) and reduced time below 90% oxygen saturation
(B=−0.03, p=0.034).
Longitudinally, each hour increase in MVPA was associated with a 4% reduction in the odds of severe
OSA and less severe mean oxygen desaturation (B=−0.003, p=0.014), time below 90% oxygen saturation
(B=−0.02, p=0.02), and mean duration of apnoeas (B=−0.004, p=0.016).
MVPA is associated with reduced hypoxaemia in a cohort of community dwelling males, approximately
half of whom had untreated OSA. As nocturnal intermittent hypoxaemia is associated with
cardiometabolic disorders, MVPA may offer protection for patients with OSA.
@ERSpublications
This study provides epidemiological evidence that moderate to vigorous physical activity is
associated with less severe OSA-induced hypoxaemia. This result suggests that MVPA should be
actively implemented in treatment regimens for people with OSA. https://bit.ly/3a9asiZ
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Obstructive sleep apnoea (OSA) is the recurrent reduction (hypopnoea), or complete cessation (apnoea), of
airflow during sleep, resulting in intermittent hypoxaemia and arousals from sleep. OSA severity is clinically
assessed by the number of apnoeas and hypopnoeas that occur each hour (apnoea/hypopnoea index (AHI)).
Severe OSA (AHI⩾30), in particular is associated with increased risk of coronary heart disease and
stroke [1], type 2 diabetes [2], and all-cause mortality [3, 4]. Recent cohort studies indicate that, whilst 10%
of the population have been diagnosed with OSA, roughly 50% of sample populations had undiagnosed
OSA [5, 6], with 26–50% of men and up to 25% women experiencing moderate-to-severe OSA.
The current standard treatment for OSA is continuous positive airway pressure (CPAP). In the majority of
patients with OSA, varying anatomical and physiological traits causes the upper airway to be collapsible
above atmospheric pressure once conscious control of the upper airway is absent during sleep [7]. As the
name implies, CPAP continuously delivers positively pressured air to prevent the upper airway from
narrowing or collapsing.
Whilst CPAP is effective at reducing the AHI to near negligible levels, compliance, defined as at least 4 h
of use per night for 70% of the nights, has historically been poor. ROTENBURG et al. [8] showed that for
each year over a 20-year period (1994–2015), up to 40% of CPAP users were “non-compliant”.
Furthermore, recent large randomised controlled trials have demonstrated that CPAP does not reduce the
chances of a secondary cardiovascular or cerebrovascular event [9], nor improve glycaemic control of type
2 diabetes [10].
In contrast, of moderate to vigorous intensity physical activity (MVPA) decreases the risk of secondary
cardiovascular and cerebrovascular events [11, 12], as well as glycaemic control of type 2 diabetes [13].
Importantly, short-term MVPA intervention studies significantly reduce AHI (for reviews, see EDWARDS
et al. [14] and MEDELSON et al. [15]). MVPA is effective at reducing BMI through reductions in adiposity,
which is a modifiable risk factor for OSA [16], whereas CPAP has very little effect on BMI or weight
distribution [17]. A recent cohort study showed more time spent undertaking MVPA was associated with
decreased prevalence of self-reported diagnosis of OSA but could not provide data on OSA severity [18].
Likewise, another cohort study showed more time spent undertaking MVPA was associated with reduced
odds of polysomnography measured moderate to severe OSA [19]. Their models, however, only adjusted
for age and BMI, and no other known important determinants of OSA [19].
Therefore, the aim of this study was to determine the cross-sectional associations between MVPA and the
presence and severity of OSA, and the associations between changes in MVPA over time and the presence
and severity of OSA, whilst adjusting for known determinants of OSA.
Materials and methods
Participants
Data for this study was collected as part of the Men Androgen Inflammation Lifestyle Environment and
Stress (MAILES) Study and has been described in detail previously [20]. Briefly, the MAILES cohort was a
combination of two existing cohorts (the North West Adelaide Health Study, and the Florey Adelaide
Male Aging Study). These cohorts consisted of randomly selected community-dwelling men living in
Adelaide, SA, Australia (2002–2006), recruited using the same sampling frame and methodology.
Recruitment occurred by random selection of phone numbers from the electronic telephone directory.
Participants who were willing to be involved underwent computer-assisted telephone interviews, answered
detailed questions regarding biographical, sociodemographic, co-morbidities and lifestyle risk factors.
Participants also underwent a clinical assessment including anthropometry, sphygmomanometer and a
fasting blood sample.
The study was approved by both the North West Adelaide Health Service (approval number 201005) and
the Royal Adelaide Hospital institutional ethics committee (approval number 02305H). All participants
gave written informed consent, with consent collected for each new data collection stage.
Polysomnography
In 2010, a computer assisted telephone interview (n=1629) identified 1445 participants without a previous
diagnosis of OSA by polysomnography (PSG). These men were invited by to participate in an in-home
PSG (Embletta X100; Embla Systems, Thornton, CO, USA) with 1087 (75.2%) agreeing. By the conclusion
of the study period, 861 PSGs had been attempted, including repeated PSGs due to initial failure.
The PSG measured electroencephalography (EEG), electrooculography, chin electromyography, nasal
pressure, thoracic and abdominal effort, peripheral pulse oximetry and body position. Trained staff visited
study participants in their homes to set-up the sleep study, as well as record height and weight
measurements. A single experienced PSG technician, who was blinded to all other survey and biomedical
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data, performed manual scoring of PSGs according to 2007 American Academy of Sleep Medicine
(alternate) criteria [21], which is recommended for use in prospective epidemiological studies. Studies were
considered acceptable with 3.5 h of sleep and 5.5 h of total recorded study time. Hypopnoeas were a 50%
or more reduction in airflow coupled with either: 1) at least a 3% oxygen desaturation, or 2) an EEG
arousal. Apnoeas were a 10-s cessation of airflow. OSA severity was categorised as: mild (AHI 10–19
events·h−1), moderate (AHI 20–29 events·h−1) and severe (AHI >30 events·h−1). The cut-offs for
classification were chosen because RUEHLAND et al. [22] showed that an AHI of 5 events·h−1 used to define
sleep disordered breathing scored by the “recommended” American Academy of Sleep Medicine (AASM)
criteria is equivalent to an AHI of 10 events·h−1 of sleep using the alternate AASM definition.
The PSG provided the following OSA variables; AHI (events·h−1), mean duration of apnoeas and hypopnoeas
(seconds), AHI during rapid eye movement sleep (REM AHI), mean oxygen desaturation (%), and percent of
time spent below 90% oxygen saturation (T90%). Participants were removed if their oxygen saturation was
deemed of poor quality, determined by either; having an AHI <10 events·h−1 but had >20% of the night
below T90%, or spent more than 20% of the night below T90%, yet had no time below 80% oxygen saturation.
Physical activity questionnaire
Physical activity was measured by the Active Australia Survey [23]. During initial recruitment
(2002–2006), participants completed the 1999 version of the questionnaire (then called the National
Physical Activity Survey), which asked for the amount of time spent, in minutes, undertaking walking,
moderated physical activity, and vigorous physical activity, over the past two weeks [24]. In 2010,
participants completed an updated version of the questionnaire [23], which assessed activity over the
previous week instead of the past two weeks (herein referred to as MVPA-2010).
To synthesise the results from both questionnaires, the values recorded during baseline by the National
Physical Activity Survey were halved. Furthermore, vigorous physical activity levels in both questionnaires
was given twice the weight of both walking and moderate vigorous physical activity, as per guidelines for
both versions of the questionnaire [23, 24]. Thus, the MVPA levels for both questionnaires was the
addition of the adjusted vigorous values with the unadjusted moderate and walking values. Longitudinal
changes in MVPA levels were calculated by subtracting the baseline MVPA (2002–2006) from the 2010
MVPA assessment (herein referred to as MVPA-Δ).
To increase interpretability of the MVPA values, both MVPA-2010 and MVPA-Δ were converted to hours
per week. Participants who reported more than 56 h·week−1 for the MVPA-2010 (i.e. more than 8 h·day−1,
which allows those in active professions, such as the construction industry, to be included in the analysis),
or more than 56 h·week−1 of change in MVPA-Δ, were excluded, as these values were considered
unrealistic, suggesting the participant answered the question incorrectly.
Statistical analysis
Multinomial logistic regressions and linear models were used in this analysis, both of which adjusted for
confounders. Confounders were determined by examining known or suspected determinants of both AHI
and T90% in univariate models. Covariates with a p<0.1 for both AHI and T90% were included in all
analyses. The following variables were included as confounders: age, BMI, study group, income,
testosterone (log transformed), inflammation using C-reactive protein (log-transformed), diabetes,
cardiovascular disease, hypertension and smoking status. Additionally, for MVPA-Δ, we also adjusted for
baseline MVPA levels in hours. Details on collection methods of the known or suspected confounders, as
well as results for the univariate analyses, are in the online supplementary material (Supplement S1).
Multinomial logistic regression analysis was used to determine the likelihood of the dependent variable,
the OSA severity category associated with MVPA-2010 and MVPA-Δ. For the linear regression models,
the continuous dependent variables were AHI, REM AHI, mean oxygen desaturation, T90% and mean
duration of apnoeas and hypopnoeas. These metrics were all normalised by log transformation, however,
to increase interpretability of the level of change in OSA/hypoxaemia metric associated with an hour
change in MVPA-2010 and MVPA-Δ, the regression coefficients were exponentially transformed. A
further analysis is presented in the supplementary material (Supplement S2), which examines differences
in OSA indices between participants who increased, and those who decreased, MVPA by at least five
hours (300 min) between baseline and 2010.
All statistical analyses were calculated in R (v3.1.0, R Foundation for Statistical Computing, Vienna,
Austria), and utilised the “LSR” and “NNET” packages. All models were assessed for linearity and
homoscedasticity (residual versus fitted plots and scale-location plots), normal distribution of residuals
(Q-Q plot), and influential values (Cooks D>0.5). A p-value <0.05 was considered significant. Figures were
created in Prism (GraphPad Software, San Diego, CA, USA).
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Results
Participants
Figure 1 illustrates the derivation of the final analysis set; 34 participants were excluded due to inadequate
OSA data, whilst an additional 25 participants were removed from the T90% analysis due to potential
signal quality issues. Nine participants were excluded for reporting more than 56 h·week−1 of MVPA,
whilst a further four were excluded for reporting a change or more than 56 h·week−1. This resulted in the
analysis of 789 participants, whose characteristics are outlined in table 1. One participant was excluded
from the analysis for mean oxygen desaturation due to be an influential value according to the Cook’s D
of 0.5.
Associations between MVPA-2010 with OSA severity categories and nocturnal hypoxaemia
metrics
Multinomial logistic regressions indicated that each hour of MVPA was associated with modest but
nonsignificant reduced odds for both mild OSA (OR 0.976, 95% CI 0.95–1.01; p=0.11) and severe OSA
(OR=0.96, 95% CI 0.91–1.01; p=0.09), and a small, nonsignificant increased odds of moderate OSA
(OR=1.01, 95% CI 0.98–1.04; p=0.54).
Forest plots derived from adjusted linear regressions examining cross-sectional associations between
MVPA and OSA metrics are shown in figure 2. More time spent undertaking MVPA-2010 was associated
with reduced mean oxygen desaturation (unstandardised β (B)=−0.002, p=0.043) and reduced T90%
(B=−0.03, p=0.034). No significant associations occurred with AHI (b=−0.01, p=0.15), REM AHI
(B=−0.005, p=0.59), or the duration of apnoeas (B=−0.001, p=0.38) and hypopnoeas (B=−0.001,
p=0.58).
MAILES computer assisted telephone interview, 2010:
second assessment of physical activity and prior OSA
diagnosis, n=1445  
Participants with valid polysomnography data, n=827
MAILES participants who underwent polysomnography,
2010–2011, n=861  
Participants with valid MVPA data, n=789 
Participants reporting
  >56 h of MVPA per week, 
  n=13  
Participants with oxygen
  saturation irregularities,
  n=25  
No data recorded, n=24
Excess periods of no
  oxygen saturation
  recording, n=10   
Prior OSA diagnosis, n=184 
MAILES baseline recruitment: first assessment of physical
(FAMAS n=1195, NWAHS n=1368) 
FIGURE 1 Consort diagram showing number, and reasons, for exclusion from analysis. MAILES: Men
Androgen Inflammation Lifestyle Environment and Stress; FAMAS: Florey Adelaide Men’s Aging Study;
NWAHS: North West Adelaide Health Study; OSA: obstructive sleep apnea; MVPA: moderate to vigorous
physical activity.
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A sensitivity analysis (not included) indicates that when participants with pulse oximetry irregularities
were included in the linear regressions, no differences in associations between MVPA-2010 and OSA
indices occurred.
Associations between MVPA-Δ with OSA severity categories and nocturnal hypoxaemia metrics
Multinomial logistic regressions indicated that each hour increase in MVPA-Δ was associated with a small,
nonsignificant reduced odds of mild OSA (OR 0.980, 95% CI 0.96–1.01; p=0.12), no change in odds of
moderate OSA (OR 1.00, 95% CI 0.97–1.03; p=0.89) and a moderate, significant reduced odds of severe
OSA (OR 0.960, 95% CI 0.93–0.99; p=0.03).
Forest plots derived from adjusted linear regressions examining associations between MVPA-Δ and OSA
metrics are shown in figure 3. There were significant inverse associations between MVPA-Δ and mean
oxygen desaturation (B=−0.003, p=0.014), T90% (B=−0.02, p=0.02), and mean duration of apnoeas
(B=−0.004, p=0.016). No significant associations occurred with AHI (B=−0.008, p=0.17), REM AHI
(B=0.001, p=0.88) or duration of hypopneas (B=−0.001, p=0.27). For interpretability, the change in each
metric per hour of MVPA-2010 is shown in table 2.
A sensitivity analysis (not included) indicates that when participants with pulse oximetry irregularities
were included in the linear regressions, T90% was no longer associated with MVPA-Δ (B=−0.015, p=0.07).
No other changes in associations occurred.
TABLE 1 Polysomnographic characteristics of study participants
Age years 60±17
Body mass index kg·m−2 28.5±5.3
AHI events·h−1 15.7±15.2
REM AHI events·h−1 19.0±20.0
Mean oxygen desaturation % 4.2±1.0
T90% % 3.5±3.4
Mean hypopnoea duration s 23.2±6.0
Mean apnoea duration s 21.3±8.2
MVPA-2010 h 4.5±5.6
MVPA-Δ h 0.3±4.3
Data are presented as median±interquartile range. AHI: apnoea/hypopnoea index; REM: rapid eye
movement; T90%: amount of sleep with oxygen saturation <90%; MVPA: moderate to vigorous physical
activity; MVPA-2010: time spent undertaking MVPA during 2010 collection; MVPA-Δ: change in time spent
undertaking MVPA from baseline (2002–2006) to 2010.
AHI events⋅h–1
REM AHI events⋅h–1







FIGURE 2 Cross-sectional associations between moderate to vigorous physical activity (MVPA) in 2010 and
obstructive sleep apnea metrics. X-axis indicates log-transformed unstandardised β. Adjustments: age, body
mass index, study group (Florey Adelaide Men’s Aging Study versus North West Adelaide Health Study),
income, serum testosterone, serum C-reactive protein, cardiovascular disease status, diabetes status,
hypertension status, Missing data: MVPA difference: 36; income: 20; testosterone: 66; inflammation: 65;
diabetes status: 12; cardiovascular disease status: 14; blood pressure: 26; mean O2 desaturation: 1. AHI:
apnoea/hypopnoea index; REM: rapid eye movement; T90%: amount of sleep with oxygen saturation <90%.
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Discussion
This study highlights spending more time engaged in MVPA was associated with less severe nocturnal
hypoxaemia indices, but in cross-sectional analyses was not associated with AHI or REM AHI. The same
associations with hypoxaemia indices persisted when we examined the changes in time spent engaging in
MVPA from baseline (2002–2006) to 2010, suggesting this is a robust finding. Furthermore, increasing
MVPA over time was associated with significantly reduced odds of severe OSA.
The results of this study are consistent with the cross-sectional data of DA SILVA et al. [19], despite this
study utilising more stringent adjustments for known confounders of OSA, and the different physical
activity questionnaires used. Importantly, to our knowledge, this is the first study to examine associations
of longitudinal changes in MVPA on OSA metrics. Thus, this study adds further evidence highlighting the
potential benefits of MVPA in reducing the severity of OSA [14, 15].
A novel finding of this study was the significant association between increasing the amount of time
undertaking MVPA between baseline and 2010 and shorter mean duration of apnoeas, along with the
nonsignificant association with shorter mean duration of hypopnoeas. This is clinically important, as
longer duration of apnoeas and hypopnoeas are associated with increased prevalence and severity of
hypertension [25–27], and increased prevalence of cardiovascular disease [28]. The reductions in apnoea
duration, but not hypopnoea duration, may provide a mechanism as to why increased MVPA over time
may improve hypoxaemia. Yet, as MVPA-2010 was not associated with either apnoea or hypopnoea mean
duration but was associated with improved hypoxaemia indices, changed in MVPA must affect other
contributors to OSA and hypoxaemia severity.
AHI events⋅h–1
REM AHI events⋅h–1





–0.04 –0.02 0.00 0.02
FIGURE 3 Cross-sectional associations between changes in moderate to vigorous physical activity (MVPA) from
baseline (2002–2006) to 2010 (MVPA-Δ) and obstructive sleep apnea metrics. X-axis indicates log-transformed
unstandardised β. Adjustments: age, body mass index, study group (Florey Adelaide Men’s Aging Study versus
North West Adelaide Health Study), income, serum testosterone, serum C-reactive protein, cardiovascular
disease status, diabetes status, hypertension status Missing data: MVPA: 35; income: 20; testosterone: 66;
inflammation: 65; diabetes status: 12; cardiovascular disease status: 14; blood pressure: 26; mean O2
desaturation: 1. AHI: apnoea/hypopnoea index; REM: rapid eye movement; T90%: amount of sleep with oxygen
saturation <90%.
TABLE 2 Percentage change in obstructive sleep apnoea (OSA) metrics for each hour increase
in MVPA-2010 and MVPA-Δ
OSA index MVPA-2010 MVPA-Δ
AHI events·h−1 −0.5 −0.6
REM AHI events·h−1 −0.1 −0.1
Mean oxygen desaturation % −0.2# −0.3#
T90% % −2.0# −1.5#
Mean hypopnoea duration s −0.06 −0.1
Mean apnoea duration s −0.14 −0.35#
MVPA-2010: time spent undertaking moderate to vigorous physical activity (MVPA) during 2010 collection;
MVPA-Δ: change in time spent undertaking MVPA from baseline (2002–2006) to 2010; AHI: apnoea/
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Anatomically, MVPA reduces the fat mass around the upper airway and in the tongue, which has been
shown to improve symptoms of OSA [29, 30]. In addition, increased MVPA may target non-anatomical
contributors of OSA. For example, the upper airway muscles of patients with OSA fatigue easily, meaning
people with OSA are predisposed to experiencing narrowing and collapsing of the upper airway during
sleep [31]. In adults without OSA, MVPA results in upper airway muscles that are less susceptible to
fatigue [32, 33]. Another non-anatomical contributor is unstable respiratory control, where a person
experiences cycles of hyperventilation and hypoventilation due to small changes in blood gasses. Adults
who regularly undertake MVPA show more stable respiratory control [34]. Importantly, similar results
have been shown in adults with congestive heart failure, a condition increases a person’s susceptibility to
unstable respiratory control [35]. As these potential mechanisms have not been examined, however, it
remains uncertain why undertaking MVPA is associated with reduced odds of severe OSA and less severe
nocturnal hypoxaemia indices, and therefore should be the focus of future research.
Although the changes in hypoxaemia indices per hour of MPVA in this study were not large,
epidemiological studies examining other heath conditions have shown small improvements convey large
protective benefits at a population level. For example, a 2-mmHg reduction in systolic blood pressure
reduced the risk of death due to ischaemic heart disease and stroke by 7% and 10% respectively [36].
Similarly, in the UK, a 1% improvement in HbA1c resulted in approximately GBP 2.5bn reduction over
25 years in healthcare costs due to complications from diabetes [37].
The strength of this study lies in the clinical polysomnography collected in a large cohort of participants
representative of the urban dwelling population. A further strength of this study is longitudinal nature of
the MVPA data, with the Active Australia questionnaires already used extensively in other epidemiological
studies [38, 39].
Only examining the male population can be considered a limitation of this study, as the findings cannot
be applied to women. A further limitation is the lack of objectively measured MVPA data; however, as
large scale actigraphy measurement was unfeasible until the mid-2010s, this was unavoidable.
As there has only been small, short-duration studies examining the effect of MVPA interventions on OSA,
future large randomised, controlled trials are needed to determine the effect of undertaking MVPA
without CPAP, and the combination of both MVPA and CPAP, has on OSA severity indices. Additionally,
future studies should examine potential mechanisms by which MPVA improves hypoxaemia indices. To
do this, longitudinal changes in OSA metrics, as well as studies that can directly measure the anatomical
and non-anatomical contributors to OSA, are needed. Importantly, all future studies should objectively
measure MVPA by actigraphy, as well as examine all genders.
Our study provides evidence more time spent undertaking MVPA was associated with lower odds of severe
OSA, and less severe hypoxaemia. Importantly, whilst CPAP is effective at eliminating hypoxaemia [40],
cardiovascular and metabolic health problems still remain in patients with OSA [9, 10]. Therefore, the
results of this study, when coupled with the well-established benefits of MVPA on other health conditions
[11–13], suggest that MVPA should be prescribed for all patients with OSA.
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